Article
p53 mutations in hepatocellular carcinoma related to oral contraceptive use.
Carcinogenesis - 1 Jan 1996
De Benedetti V M, Welsh J A, Yu M C, Bennett W P
Abstract excerpt
Oral contraceptives (OCs) are implicated in the development of hepatocellular carcinoma (HCC). Mitogenic stimulation may be the primary mechanism of tumorigenesis, but other factors may also contribute. Mutational spectrum analysis can provide insights into pathogenesis, therefore we analyzed the p53 tumor suppressor gene in 10 HCCs from women with a history of OC use. All were non-Asians whose average OC use was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
